Skip to content

A prospective comparative study on the efficiency and safety of TUVRP for the treatment of Benign Prostatic Hyperplasia with prostate volumn greater than 80ml

A prospective comparative study on the efficiency and safety of TUVRP for the treatment of Benign Prostatic Hyperplasia with prostate volumn greater than 80ml

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OCH-12002778
Enrollment
Unknown
Registered
2012-10-16
Start date
2013-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

benign prostatic hyperplasia

Interventions

GroupA:Prostate volume=80ml

Sponsors

The First affiliated Hospital to the Third Military Medical University, Chongqing, China
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
45 Years to 100 Years

Inclusion criteria

Inclusion criteria: The male patients which are diagnosed BPH with age greater than 45 yearsold, must meet one or more following criterias: 1. Repeated urine retention; 2. Repeated hematuria; 3. Repeated infection of urinary system; 4. The formation of bladder stone; 5. Secondary hydronephrosis.

Exclusion criteria

Exclusion criteria: 1. Patients with progressive malignant tumor; 2. Detrusor weakness; 3. Patients with urethral stricture; 4. Uncontrolled urinary tract infection; 5. Central nervous system diseases or peripheral neuropathy; 6. With serious cardiopulmonary disease; 7. Coagulation diaorders.

Design outcomes

Primary

MeasureTime frame
Maximum flow rate (QMax);international prostate symptom score;quality life score;

Secondary

MeasureTime frame
transrectal Doppler examination of prostate;prostate specific antigen;Operation time;Amount of bleeding in operation;The weight of prostate tissue be cut off;

Countries

China

Contacts

Public ContactWenhao Shen
chongqingswh@yahoo.com.cn+86 13983842766

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026